Response to: 'Correspondence on 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Fallon et al

Author(s):: Baraliakos, X.; Gossec, L.; McInnes, I.; Kerschbaumer, A.; Wit, M. de; Dougados, M.; Primdahl, J.; Heijde, D. van der; Smolen, J.S.

Published: 2022
Publication type: Article / Letter to editor

arthritispsoriatictherapeuticsautoimmune Diseases

Date issued: 2022-09-01
Language: English
Publisher: BMJ PUBLISHING GROUP
Is part of
hdl: 1887/3458783
doi: 10.1136/annrheumdis-2020-218676
URL: https://ard.bmj.com/content/81/9/e174